Short answer
Pennant Group, Inc. (PNTG) filed an 8-K current report with the SEC on August 5, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Q2 2026 results for quarter ended June 30, 2026.
Pennant Group, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q2 2026 results for quarter ended June 30, 2026
- Press release issued August 5, 2026
- Detailed financial results and management commentary in Exhibit 99.1
Item 7.01 · Regulation FD Disclosure
- Updated investor presentation intended for upcoming investor meetings
- Materials available at investor.pennantgroup.com
- Potential investor relevance limited to management’s latest messaging and priorities disclosed in the presentation
Item EX-99.1 · Exhibit EX-99.1
- Q2 revenue $298.0M, up 35.8%, with GAAP diluted EPS $0.25 and adjusted EPS $0.36
- Adjusted EBITDA $24.3M, up 48.2%, outpacing revenue growth and signaling operating leverage
- Home health and hospice revenue $237.8M, up 43.2%, driven by admissions growth and recently acquired operations
- Same-store home health admissions rose 9.7%, while same-store hospice census increased 10.8%, indicating underlying organic momentum
- 2026 guidance raised to revenue $1,171.1M-$1,190.1M, adjusted EPS $1.34-$1.41, and adjusted EBITDA $94.4M-$98.0M
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Pennant Group, Inc. 8-K filings
Get the next PNTG 8-K as it lands
Follow PNTG for push alerts, or ask the research agent what this filing means.